Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Total Assets: TND0.00 Mil (As of . 20)


XTUN:SIPHA Societe des Industries Pharmaceutiques de Tunisie-S I PHA T XTUN:SIPHA
12 GF Score
Price TND4.01
! 1 Warning Sign
View Full Analysis

What is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Total Assets?

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T XTUN:SIPHA 12 Total Assets is TND0.00 Mil as of . 20. GuruFocus rates XTUN:SIPHA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Total Assets for the quarter that ended in . 20 was TND0.00 Mil.

Total Assets is connected with ROA %. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's annualized ROA % for the quarter that ended in . 20 was %. Total Assets is also linked to Revenue through Asset Turnover. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Asset Turnover for the quarter that ended in . 20 was .

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T  (XTUN:SIPHA) Total Assets Explanation

Total Assets is connected with ROA %.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's annualized ROA % for the quarter that ended in . 20 is

ROA %=Net Income (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

Note: The Net Income data used here is one times the annual (. 20) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Asset Turnover for the quarter that ended in . 20 is

Asset Turnover
=Revenue (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Total Assets Related Terms

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Total Assets Historical Data

* Premium members only.

The historical data trend for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Total Assets Chart

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Annual Data
Trend
Total Assets

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Semi-Annual Data
Total Assets
XTUN:SIPHA
12GF Score
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T XTUN:SIPHA
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Total Assets for the fiscal year that ended in . 20 is calculated as

Total Assets=Total Equity (A: . 20 )+Total Liabilities (A: . 20 )
=N/A+N/A
=N/A

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Total Assets for the quarter that ended in . 20 is calculated as

Total Assets=Total Equity (Q: . 20 )+Total Liabilities (Q: . 20 )
=N/A+N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of TND0.00 Mil mean?
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) has a Total Assets of TND0.00 Mil as of . 20. The total amount of assets as recorded on a company's balance sheet. View historical data on Societe des Industries Pharmaceutiques de Tunisie-S I PHA T and its competitors.
Is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Total Assets too high?
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's current Total Assets is TND0.00 Mil. Overall, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Total Assets compare to BIEI and PTXTQ?
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Total Assets of TND0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Societe des Industries Pharmaceutiques de Tunisie-S I PHA T and its competitors. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's current Total Assets is TND0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T stock overvalued right now?
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) has a current Total Assets of TND0.00 Mil. The current Total Assets is TND0.00 Mil. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA), the current Total Assets is TND0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Business Description

Address Fondouk Choucha, Ben Arous, TUN, 2013
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T is a Tunisia-based company mainly engaged in manufacturing and distributing medicines and drugs. The company also has its own research and development process to develop generic drugs. It offers pharmaceutical, dietary, hygiene, and cosmetic products in dry, liquid and pasty forms.
12GF Score

Get the complete analysis for XTUN:SIPHA

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

TND4.01
Price